Common use of GSK Clause in Contracts

GSK. GSK warrants and represents to Unigene that, as of the Amendment Effective Date: (i) it has the full right and authority to enter into this Agreement; (ii) there are no existing or threatened actions, suits or claims pending against it with respect to its right to enter into and perform its obligations under this Agreement; (iii) it has not granted, and it will not grant during the Term of this Agreement, any right, license or interest in or to the Licensed Technology, GSK Patent Rights, GSK Know-How, Joint Patent Rights, and/or Joint Inventions which is in conflict with the rights or licenses granted to Unigene under this Agreement; (iv) there is nothing in any Third Party agreement GSK has entered into which, in any way, will limit GSK’s ability to perform all of the obligations undertaken by GSK hereunder, and it will not enter into any agreement after the Effective Date under which GSK would incur any such limitations; and (v) to the best of its knowledge, it has not intentionally omitted to furnish Unigene with any information requested by Unigene, nor has it intentionally concealed from Unigene any information in its possession concerning PTH or Licensed Product, or anticipated components thereof, or the transactions contemplated by this Agreement, which would be material to Unigene’s decision to enter into this Agreement and to undertake the commitments and obligations set forth herein. (vi) to the best of its knowledge, there is nothing in any Third Party agreement GSK has entered into which will limit in any way GSK’s ability to perform all of the obligations undertaken by GSK hereunder, and it will not enter into any agreement after the Amendment Effective Date under which GSK would incur any such limitations.

GSK. GSK warrants and represents to Unigene that, as of the Amendment Effective Date: (i) as of the Effective Date, it has the full right and authority to enter into this Agreement; (ii) as of the Effective Date, there are no existing or threatened actions, suits or claims pending against it with respect to its right to enter into and perform its obligations under this Agreement; (iii) as of the Effective Date, it has not granted, and it will not grant during the Term of this Agreement, any right, license or interest in or to the Licensed Technology, GSK Patent Rights, GSK Know-How, Joint Patent Rights, and/or Joint Inventions which is in conflict with the rights or licenses granted to Unigene under this Agreement; (iv) there is nothing in any Third Party agreement GSK has entered into as of the Effective Date, which, in any way, will limit GSK’s ability to perform all of the obligations undertaken by GSK hereunder, and that it will not enter into any agreement after the Effective Date under which GSK would incur any such limitations; and; (v) as of the Effective Date, to the best of its knowledge, it has not no knowledge of any matter which would allow GSK to terminate the Agreement pursuant to Article 10.4, nor has it intentionally omitted to furnish Unigene with any information requested by UnigeneGSK, nor has it intentionally concealed from Unigene any information in its possession concerning PTH or Licensed Product, or anticipated components thereof, or the transactions contemplated by this Agreement, which would be material to Unigene’s decision to enter into this Agreement and to undertake the commitments and obligations set forth herein.; and (vi) it is not a party to the best of its knowledge, there is nothing in any agreement or arrangement with any Third Party agreement GSK has entered into or under any obligation or restriction which will limit in any way GSK’s limits or conflicts with its ability to perform all fulfill any of the its obligations undertaken by GSK hereunderunder this Agreement, and it will shall not enter into any such agreement after or arrangement during the Amendment Effective Date under which GSK would incur any such limitationsTerm of this Agreement.

GSK. GSK warrants and represents to Unigene that, as of the Amendment Effective Date:: --- (i) as of the Effective Date, it has the full right and authority to enter into this Agreement; (ii) as of the Effective Date, there are no existing or threatened actions, suits or claims pending against it with respect to its right to enter into and perform its obligations under this Agreement; (iii) as of the Effective Date, it has not granted, and it will not grant during the Term of this Agreement, any right, license or interest in or to the Licensed Technology, GSK Patent Rights, GSK Know-How, Joint Patent Rights, and/or Joint ** Certain information on this page has been omitted and filed separately with the Commission. Confidential treatment has been requested with respect to the omitted portions. Inventions which is in conflict with the rights or licenses granted to Unigene under this Agreement; (iv) there is nothing in any Third Party agreement GSK has entered into as of the Effective Date, which, in any way, will limit GSK’s 's ability to perform all of the obligations undertaken by GSK hereunder, and that it will not enter into any agreement after the Effective Date under which GSK would incur any such limitations; and; (v) as of the Effective Date, to the best of its knowledge, it has not no knowledge of any matter which would allow GSK to terminate the Agreement pursuant to Article 10.4, nor has it intentionally omitted to furnish Unigene with any information requested by UnigeneGSK, nor has it intentionally concealed from Unigene any information in its possession concerning PTH or Licensed Product, or anticipated components thereof, or the transactions contemplated by this Agreement, which would be material to Unigene’s 's decision to enter into this Agreement and to undertake the commitments and obligations set forth herein.; and (vi) it is not a party to the best of its knowledge, there is nothing in any agreement or arrangement with any Third Party agreement GSK has entered into or under any obligation or restriction which will limit in any way GSK’s limits or conflicts with its ability to perform all fulfill any of the its obligations undertaken by GSK hereunderunder this Agreement, and it will shall not enter into any such agreement after or arrangement during the Amendment Effective Date under which GSK would incur any such limitationsTerm of this Agreement.